Skip to main content

Table 1 Summary statistics for HARP-2, ALTA, EDEN and SAILS

From: Re-analysis of ventilator-free days (VFD) in acute respiratory distress syndrome (ARDS) studies

Study

VFD score

VFD score for survivorsa

VFD score for patients achieving UBb

HARP-2

All

Placebo

Simvastatin

All

Placebo

Simvastatin

All

Placebo

Simvastatin

N

537

279

258

405

204

201

353

170

180

 Mean (SD)

12.0 (10.2)

11.5 (10.4)

12.6 (9.9)

15.9 (8.70)

15.8 (9.1)

16.1 (8.3)

18.2 (6.6)

18.7 (6.4)

17.8 (6.8)

 Median (IQR)

13 (0, 22)

12 (0, 22)

14 (0, 22)

19 (10 to 23)

19 (9, 23)

19 (10, 23)

20 (14, 23)

20 (14, 24)

20 (14, 23)

 Min to Max

0 to 27

0 to 27

0 to 27

0 to 27

0 to 27

0 to 27

2 to 27

2 to 27

2 to 27

ALTA

All

Placebo

Albuterol

All

Placebo

Albuterol

All

Placebo

Albuterol

N

282

130

152

233

112

121

205

102

103

 Mean (SD)

15.4 (10.6)

16.6 (10.0)

14.4 (11.1)

18.6 (8.7)

19.3 (8.1)

18.0 (9.4)

21.2 (5.8)

21.1 (5.6)

21.2 (6.0)

 Median (IQR)

20 (0, 24)

21 (7, 24)

20 (0, 24.5)

22 (15 to 25)

22 (17, 25)

22 (13, 25)

23 (19, 26)

23 (17, 25)

23 (19, 25)

 Min to Max

0 to 28

0 to 28

0 to 28

0 to 28

0 to 28

0 to 28

2 to 28

2 to 28

2 to 28

EDEN

All

Full

Tropic

All

Full

Tropic

All

Full

Tropic

N

1000

492

508

806

397

409

696

351

345

 Mean (SD)

14.9 (10.8)

15.0 (10.6)

14.9 (10.9)

18.5 (8.8)

18.6 (8.5)

18.5 (9.1)

21.3 (5.5)

21 (5.5)

21.6 (5.4)

 Median (IQR)

20 (0, 24)

19.5 (0, 24)

20 (0, 25)

22 (15 to 25)

22 (16 to 25)

22 (15 to 25)

23 (19, 25)

23 (18, 25)

23 (20, 25)

 Min to Max

0 to 28

0 to 28

0 to 28

0 to 28

0 to 28

0 to 28

1 to 28

1 to 28

1 to 28

SAILS

All

Placebo

Rosuvastatin

All

Placebo

Rosuvastatin

All

Placebo

Rosuvastatin

N

745

366

379

573

285

288

515

251

264

 Mean (SD)

15.1 (10.9)

15.1 (11.0)

15.1 (10.8)

19.6 (8.1)

19.4 (8.5)

19.8 (7.7)

21.8 (5.2)

21.9 (5.2)

21.6 (5.1)

 Median (IQR)

20 (0, 25)

20 (0, 25)

20 (0, 25)

23 (17, 25)

23 (17, 25)

23 (17, 25)

23 (20, 26)

23 (20, 26)

24 (19.5, 25.5)

 Min to max

0 to 28

0 to 28

0 to 28

0 to 28

0 to 28

0 to 28

1 to 28

2 to 28

1 to 28

  1. a0 s due to 28-day mortality are excluded
  2. b0 s due to 28-day mortality or prolonged ventilation are excluded